Laboratory of Physiology and Explorations, Faculty of Medicine Sousse, University of Sousse, Sousse, Tunisia.
Heart Failure (LR12SP09) Research Laboratory, Farhat Hached Hospital, Sousse, Tunisia.
J Obes. 2020 Feb 10;2020:8075482. doi: 10.1155/2020/8075482. eCollection 2020.
To analyze the ventilatory and alveolar-capillary diffusion dysfunctions in case of obesity with or without an OSAS.
It is a cross-sectional study of 48 obese adults (23 OSAS and 25 controls). Anthropometric data (height, weight, and body mass index (BMI)) were collected. All adults responded to a medical questionnaire and underwent polysomnography or sleep polygraphy for apnea-hypopnea index (AHI) and percentage of desaturation measurements. The following lung function data were collected: pulmonary flows and volumes, lung transfer factor for carbon monoxide (DLCO), and fraction of exhaled nitric oxide (FNO).
Obesity was confirmed for the two groups with a total sample mean value of BMI = 35.06 ± 4.68 kg/m. A significant decrease in lung function was noted in patients with OSAS compared with controls. Indeed, when compared with the control group, the OSAS one had a severe restrictive ventilatory defect (total lung capacity: 93 ± 14 vs. 79 ± 12%), an abnormal DLCO (112 ± 20 vs. 93 ± 22%), and higher bronchial inflammation (18.40 ± 9.20 vs. 31.30 ± 13.60 ppb) ( < 0.05).
Obesity when associated with OSAS increases the severity of pulmonary function and alveolar-capillary diffusion alteration. This can be explained in part by the alveolar inflammation.
分析肥胖症伴或不伴阻塞性睡眠呼吸暂停低通气综合征(OSAS)患者的通气和肺泡毛细血管弥散功能障碍。
这是一项横断面研究,纳入了 48 名肥胖成年人(23 名 OSAS 患者和 25 名对照组)。收集了人体测量学数据(身高、体重和体重指数(BMI))。所有成年人都回答了一份医学问卷,并接受了多导睡眠图或睡眠描记术,以测量呼吸暂停低通气指数(AHI)和饱和度下降百分比。收集了以下肺功能数据:肺流量和容量、一氧化碳肺转移因子(DLCO)和呼气一氧化氮分数(FNO)。
两组的肥胖均得到证实,总样本 BMI 的平均值为 35.06±4.68kg/m。与对照组相比,OSAS 患者的肺功能显著下降。与对照组相比,OSAS 组确实存在严重的限制性通气缺陷(肺总量:93±14 比 79±12%)、异常的 DLCO(112±20 比 93±22%)和更高的支气管炎症(18.40±9.20 比 31.30±13.60 ppb)(<0.05)。
肥胖症伴 OSAS 会增加肺功能和肺泡毛细血管弥散功能障碍的严重程度。这部分可以通过肺泡炎症来解释。